Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-02
2007-10-02
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S017000, C546S018000, C546S225000, C546S229000, C514S330000, C514S331000
Reexamination Certificate
active
10566252
ABSTRACT:
The invention provides a compound which exhibits satisfactory peroral absorbability and excellent antagonistic activity against NK-1 receptor or NK-2 receptor. The compound is a benzylamine derivative represented by formula (1) or a salt thereof
REFERENCES:
patent: 5789422 (1998-08-01), Reichard et al.
patent: 5869496 (1999-02-01), Hale et al.
patent: 8-505880 (1996-06-01), None
patent: 8-511522 (1996-12-01), None
patent: 11-043490 (1999-02-01), None
patent: 2001-507673 (2001-06-01), None
patent: 2002-520316 (2002-07-01), None
patent: 94/17045 (1994-08-01), None
patent: 94/26735 (1994-11-01), None
patent: 94/29309 (1994-12-01), None
Kawase Nobuo
Murata Masakazu
Nagasawa Masaaki
Nakamura Hideki
Tanaka Nobuyuki
Aulakh Charanjit S.
Zeria Pharmaceutical Co. Ltd.
LandOfFree
Benzylamine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzylamine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzylamine derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3856346